Muscular Disorders Drug Development Summit | January 26-28, 2027 | Boston, MA The muscular disease field is entering a pivotal new chapter. Following a year of significant debate around Sarepta's […]

One year on from Vertex Pharmaceuticals' milestone JOURNAVX® approval, making history as the first new class of pain medicine in decades, non-opioid pain R&D has skyrocketed as one of biopharma’s […]